NIO Reports Upbeat Earnings, Joins Dave, V2X, Riskified And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were lower, with the Dow Jones index falling more than 200 points on Tuesday.
Shares of NIO Inc. (NYSE:NIO) rose during Tuesday’s session following upbeat quarterly results.
NIO reported fourth-quarter revenue of 17.10 billion yuan ($2.41 billion), up by 6.5% year-over-year and down by 10.3% from the previous quarter. Analysts, on average, estimated revenue of $2.29 billion for the quarter. Excluding share-based compensation expenses, the company reported an adjusted loss of (2.81) yuan or ($0.39) compared to (3.07) yuan in the year-ago quarter and (2.28) yuan in the third quarter of 2023. Analysts had called for a loss of $(0.51) per share.
NIO shares gained 3.6% to $5.52 on Tuesday.
Here are some other big stocks recording gains in today’s session.
- Apogee Therapeutics, Inc. (NASDAQ:APGE) shares gained 41.6% to $59.10 after the company announced interim results from its Phase 1 healthy volunteer trial for APG777. Also, the company reported FY23 financial results.
- Dave Inc. (NASDAQ:DAVE) surged 39.8% to $30.62 after the company reported a year-over-year increase in fourth-quarter revenue results.
- AeroVironment, Inc. (NASDAQ:AVAV) shares climbed 24.8% to $163.05 after the company reported better-than-expected results for its fourth quarter. The company said it sees FY24 adjusted earnings of $2.69 to $2.83 per share on revenue of $700 million to $710 million.
- Paymentus Holdings, Inc. (NYSE:PAY) rose 20.3% to $19.67 after the company reported better-than-expected fourth quarter financial results.
- 3D Systems Corporation (NYSE:DDD) climbed 14.7% to $4.7150. 3D Systems announced additional partial repurchase of convertible senior notes.
- Fresenius Medical Care AG (NYSE:FMS) rose 12.2% to $20.95. Fresenius Medical Care achieved next milestone in portfolio optimization program, announcing sale of dialysis clinics in Brazil, Colombia, Chile, Ecuador.
- Krystal Biotech, Inc. (NASDAQ:KRYS) gained 11.6% to $178.44.
- New York Community Bancorp, Inc. (NASDAQ:NYCB) climbed 11.3% to $3.0411 after falling 23% on Monday. New York Community Bancorp last week announced that it identified material weaknesses in its internal controls and replaced its CEO.
- Spyre Therapeutics, Inc. (NASDAQ:SYRE) gained 11.3% to $38.92. Spyre Therapeutics recently reported a year-over-year increase in fourth-quarter EPS results.
- The RealReal, Inc. (NASDAQ:REAL) rose 10.7% to $3.5450.
- V2X, Inc. (NYSE:VVX) gained 10.4% to $42.66 after the company reported better-than-expected fourth-quarter results and provided upbeat FY24 guidance.
- Scholar Rock Holding Corporation (NASDAQ:SRRK) rose 10.3% to $16.94.
- Riskified Ltd. (NYSE:RSKD) gained 8.8% to $ 4.97 after the company reported better-than-expected fourth-quarter EPS and revenue but issued guidance below estimates.
- DaVita Inc. (NYSE:DVA) rose 7.4% to $135.14. DaVita entered into agreement to expand operations in Brazil and Colombia, enter Chile and Ecuador.
- Constellation Energy Corporation (NASDAQ:CEG) gained 4.9% to $184.63. On Monday, UBS maintained a Buy rating on the stock and raised its price target from $151 to $201.
- Harley-Davidson, Inc. (NYSE:HOG) rose 4% to $38.14. DA Davidson analyst Brandon Rolle reiterated Harley-Davidson with a Buy and maintained a $42 price target.
Now Read This: Bitcoin Surpasses $65,000; Pepe Emerges As Top Gainer
